TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer

PURPOSE: Trophoblast cell surface antigen 2 (TROP2) has emerged as a promising target of antibody-drug conjugates (ADCs) for triple-negative breast cancer (TNBC), as well as other breast cancers (BCs). This study aims to investigate the biomarker value of TROP2 for patient-tailoring and prognostic f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyue, Zhou, Tianhao, Wang, Yongmei, Pei, Min, Wang, Guifeng, Chu, Wendi, Wang, Qi, Du, Shaoqian, Wang, Hongxia, Wang, Chunhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078428/
https://www.ncbi.nlm.nih.gov/pubmed/35535168
http://dx.doi.org/10.2147/OTT.S354048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078428/
https://www.ncbi.nlm.nih.gov/pubmed/35535168
http://dx.doi.org/10.2147/OTT.S354048

Ejemplares similares